A renaissance for SRC
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This suggests that SRC activation may also be a dominant feature in CRC, which is supported by the observation that SRC activation was documented in > 80% of CRC [17].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“In response signaling from a variety of RTKs (including EGFR, HER2, HER4, PDGFR, VEGFR, FGFR4, GPCR, C-MET, IL-4/IL13/IL-13Rα2, IL-6ST/IL-6R/IL-11R), SRC has been reported to mediate diverse cell signaling pathways including RAS/MAPK (proliferation), PI3K/AKT (survival), FAK (adhesion/migration/EMT), and STAT3 (angiogenesis) [17, 49, 50].”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [17]
In the citing paper
“Aberrant SRC activation has been associated with a more aggressive phenotype and a worse prognosis in CRC patients [27, 28, 39].”
From Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer (2025) · cites this paper as [39]
In the citing paper
“The c-src is a non-receptor protein tyrosine kinase with a 60-kD molecular weight.It is a member of a 9-gene family named the Src family kinases (SFKs)”
From The molecular rationale of Src inhibition in colorectal carcinomas (2014) · cites this paper as [1]
Citations
Cites
Integrins: Versatility, modulation, and signaling in cell adhesion
Hynes, R. O. (1992) · Cell · doi:10.1016/0092-8674(92)90115-s · Cited by 9,859 · cited 1×
“Focal adhesions are also disassembled during transformation, during which the integrity of these structures is disrupted, permitting increased motilit”
BackgroundCell Migration: A Physically Integrated Molecular Process
Lauffenburger, D. A., & Horwitz, A. F. (1996) · Cell · doi:10.1016/s0092-8674(00)81280-5 · Cited by 3,915 · cited 1×
“This is followed by release of adhesions and retraction of the rear en”
BackgroundGiancotti, F. G., & Ruoslahti, E. (1999) · Science · doi:10.1126/science.285.5430.1028 · Cited by 3,869
Creation of human tumour cells with defined genetic elements
Hahn, W. C., Counter, C. M., Lundberg, A. S., Beijersbergen, R. L., Brooks, M. W., & Weinberg, R. A. (1999) · Nature · doi:10.1038/22780 · Cited by 2,345 · cited 1×
“Although not yet reported for c- SRC , it has been possible to transform human fibroblasts with oncogenes such as HRAS when they are combined with human telomerase reverse transcriptase and the SV40 large T antige”
BackgroundTransforming gene product of Rous sarcoma virus phosphorylates tyrosine
Hunter, T., & Sefton, B. M. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.3.1311 · Cited by 2,332 · cited 1×
“v- src was subsequently shown to encode a tyrosine-specific protein kinas”
BackgroundThe STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · cited 1×
“STAT3 activation by v-Src has also been shown to contribute to other biological properties of cancer cells, including cell growth and survival, and tumour-cell immune evasio”
BackgroundFOCAL ADHESIONS, CONTRACTILITY, AND SIGNALING
Burridge, K., & Chrzanowska-Wodnicka, M. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.463 · Cited by 1,942 · cited 1×
“Small adhesions can transmit stong forces for rapid movement and ultimately mature into larger focal adhesion”
BackgroundReduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551 · cited 1×
“Definitive studies in transgenic mice indicate that E-cadherin is an invasion suppresso”
BackgroundA causal role for E-cadherin in the transition from adenoma to carcinoma
Perl, A.-K., Wilgenbus, P., Dahl, U., Semb, H., & Christofori, G. (1998) · Nature · doi:10.1038/32433 · Cited by 1,424 · cited 1×
“and overexpression of E-cadherin can, in fact, counteract the acquisition of the invasive phenotyp”
Background
Cited by
Items 901–999 of 999
Li, M., Lu, M., Wang, L., Zhang, Y., Yan, L., Wang, S., & Peng, T. (2025) · Chemical Science · doi:10.1039/d5sc08317f · Cited by 5
Progastrin Promotes Colorectal Cancer Stem Cell‐Like Properties via the Receptor PZR
Nguyen, J., Lafitte, M., Barbery, M., Espie, K., Jeitany, M., Larive, R. M., Boubaker-Vitre, J., Paul, C., Boublik, Y., Fourgous, E., et al. (2025) · Advanced Science · doi:10.1002/advs.202502136 · Cited by 8
van Erp, A. E. M., Hillebrandt-Roeffen, M. H. S., van Bree, N. F. H. N., Plüm, T. A., Flucke, U. E., Desar, I. M. E., Fleuren, E. D. G., van der Graaf, W. T. A., & Versleijen‐Jonkers, Y. M. H. (2022) · Sarcoma · doi:10.1155/2022/3089424 · Cited by 10
Wang, Z. (2012) · InTech eBooks · doi:10.5772/48623 · Cited by 5
“Src is a member of a ten-gene family (FYN, YES, BLK,FRK, FGR, HCK, LCK LYN, and SRMS) of non-RTKs that play a fundamental role in the regulation of cell proliferation, migration, adhesion, and tumor angiogenesis [55, 56].”
BackgroundDNA Damage, Repair and Misrepair in Cancer and in Cancer Therapy
Ana, M., Ferreira, L. M. R., Joana, F., Carlos, F., & Maria, C. (2011) · InTech eBooks · doi:10.5772/23190 · Cited by 5
“Of note was the finding that SRC is active in many human epithelial cancers (Bolen et al., 1987; Jacobs & Rubsamen, 1983; Yeatman, 2004).”
BackgroundSrc-signaling interference impairs the dissemination of blood-borne tumor cells
Siemann, D. W., Dong, M., Pampo, C., & Shi, W. (2012) · Cell and Tissue Research · doi:10.1007/s00441-012-1415-7 · Cited by 5
“In patients, Src is frequently over-expressed in malignancies (Egan et al. 1999; Irby and Yeatman 2000; Lutz et al. 1998; Yeatman 2004).”
BackgroundA Graphic Method for Identification of Novel Glioma Related Genes
Gao, Y.-F., Shu, Y., Yang, L., He, Y., Li, L., Huang, G., Li, H., & Jiang, Y. (2014) · BioMed Research International · doi:10.1155/2014/891945 · Cited by 5
“Src could also be activated by direct binding of its SH2 and SH3 domains to intracellular proteins or activated tyrosine kinase growth factor receptors [58].”
BackgroundCarter, T. Y., Gadwala, S., Chougule, A. B., Bui, A. P. N., Sanders, A. C., Chaerkady, R., Cormier, N., Cole, R. N., & Thomas, J. H. (2019) · genesis · doi:10.1002/dvg.23297 · Cited by 5
“2019;57:e23297. wileyonlinelibrary.com/journal/dvg © 2019 Wiley Periodicals, Inc. 1 of 18 https://doi.org/10.1002/dvg.23297 Klemke, 2012; Masker et al., 2007; Pedraza, Stewart, Li, & Xu, 2004; S. M. Thomas & Brugge, 1997; Webb, Jimenez, & Martin, 2000; Yeatman, 2004).”
InfluentialDwivedi, M., Mejuch, T., Waldmann, H., & Winter, R. (2017) · Angewandte Chemie · doi:10.1002/ange.201706233 · Cited by 5
Lin, Z., Zhao, Y., Li, Q., Ci, X., Ye, X., Chen, G., Tu, Q., Feng, W., Jiang, P., Zhu, S., et al. (2022) · Carcinogenesis · doi:10.1093/carcin/bgac010 · Cited by 5
Role of PDLIM4 and c-Src in breast cancer progression
Kravchenko, D. S., Frolova, E. I., Kravchenko, J. E., & Chumakov, S. P. (2016) · Molecular Biology · doi:10.1134/s002689331601009x · Cited by 5
Targeting the Src N-terminal regulatory element in cancer
Mezquita, B., Reyes‐Farias, M., & Pons, M. (2023) · Oncotarget · doi:10.18632/oncotarget.28434 · Cited by 7
“They are non-receptor protein tyrosine kinases transducing signals from the external environment to intracellular pathways essential for normal cell homeostasis [1, 2].”
BackgroundRoles of Raft-Anchored Adaptor Cbp/PAG1 in Spatial Regulation of c-Src Kinase
Saitou, T., Kajiwara, K., Oneyama, C., Suzuki, T., & Okada, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093470 · Cited by 5
“c-Src is frequently overexpressed and activated in a wide variety of human cancers [6,11,12], despite the fact that Csk is normally expressed and the c-src gene is not mutated [13,14].”
BackgroundTokuhisa, Y., Lidsky, M. E., Toshimitsu, H., Turley, R. S., Beasley, G. M., Ueno, T., Sharma, K., Augustine, C. K., & Tyler, D. S. (2013) · Annals of Surgical Oncology · doi:10.1245/s10434-013-3387-6 · Cited by 7
MacKay, H. J., & Oza, A. M. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181bf830d · Cited by 6
“Deregulated Src phosphorylation of focal adhesion and the E-cadherin/A-catenin complex contributes to the development of a migratory/invasive cellular phenotype.(59,60) Data FIGURE 1.”
BackgroundSrc activation decouples cell division orientation from cell geometry in mammalian cells
Sun, X., Qi, H., Zhang, X., Li, L., Zhang, J., Zeng, Q., Laszlo, G. S., Wei, B., Li, T., Jiang, J., et al. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.052 · Cited by 4
“The structure of c-Src protein is composed of seven parts [13,17,18]: a myristoylated N-terminal segment (SH4 domain), a unique domain, followed by SH3, SH2, linker and tyrosine kinase domains (SH1 domain), and a short C-terminal negative regulatory region.”
BackgroundDiscovery of a Covalent Inhibitor Selectively Targeting the Autophosphorylation Site of c-Src Kinase
Zhang, H., Xu, D., Huang, H., Jiang, H., Hu, L., Liu, L., Sun, G., Gao, J., Li, Y., Xia, C., et al. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00048 · Cited by 7
Fang, T., Liu, Q., Huangfu, X., Zhu, H., Sun, H., & Chen, L. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.117877 · Cited by 5
Yang, M., Nebozhyn, M., Schell, M. J., Gandhi, N. S., Pflieger, L. T., Loboda, A. P., Pledger, W. J., Soundararajan, R., Maurin, M. M., Wang, H., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13829-2 · Cited by 5
“Of note, the SRC oncogene is a non-receptor tyrosine kinase that mediates cell proliferation, survival, invasion and motility [46, 47] and is regulated by the TME [48].”
Self-citationNew approaches and targets in advanced colorectal cancer
Macarulla, T. M., Capdevila, J., Pérez-García, J. M., Ramos, F. J., Élez, E., Markman, B., Ruiz-Echarri, M., & Tabernero, J. M. (2009) · European Journal of Cancer · doi:10.1016/s0959-8049(09)70019-x · Cited by 5
In-Silico Studies of Oncogene Protein with Anti-Cancer Drugs
Baig, T., Sheikh, H., & Tripathi, P. K. (2014) · Cited by 4
A dataset resource for clinically associated phosphosites in hepatocellular carcinoma
Meng, Q., Wang, Y., Lu, D., Song, N., Zhou, H., & Zhu, H. (2022) · PROTEOMICS · doi:10.1002/pmic.202100407 · Cited by 4
Fyn, an important molecule in the brain, is a potential therapeutic target for brain tumours
Xu, C., Tang, Y. P., Lu, X., & Chen, R. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1485919 · Cited by 5
Tang, Y.-C., Ou, J., Hsu, S.-C., Huang, C., Lin, L.-M., Chang, H.-H., Wang, Y.-H., Huang, Z.-T., Sun, M., Liu, K.-J., et al. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107556 · Cited by 5
Pan‐Src Family Kinase Inhibitors Replace Sox2 during the Direct Reprogramming of Somatic Cells
Staerk, J., Lyssiotis, C. A., Medeiro, L. A., Bollong, M. J., Foreman, R. K., Zhu, S., Garcia, M. E., Gao, Q., Bouchez, L. C., Lairson, L. L., et al. (2011) · Angewandte Chemie · doi:10.1002/ange.201101042 · Cited by 5
EGFR Inhibitors as Therapeutic Agents in Head and Neck Cancer
Liu, H., Cracchiolo, J. R., Beck, T. N., Serebriiskii, I. G., & Golemis, E. A. (2014) · Springer eBooks · doi:10.1007/978-1-4614-8815-6_4 · Cited by 4
“resistance to EGFRIs, such as IGF-1R (insulin-like growth factor-1 receptor) and others [109].”
BackgroundSu, T., Li, X., Liu, N., Pan, S., Lu, J., Yang, J., & Zhang, Z. (2012) · Journal of Biomedical Optics · doi:10.1117/1.jbo.17.7.076015 · Cited by 4
“including phosphorylation/de-phosphorylation, protein-protein interactions, and spatial localization.(19) Additionally, it was recently proposed that Src activity is regulated by redox modification via H2O2-mediated oxidation at cysteine residues.”
BackgroundMbt/PAK4 together with SRC modulates N-Cadherin adherens junctions in the developingDrosophilaeye
Pütz, S. M. (2019) · Biology Open · doi:10.1242/bio.038406 · Cited by 5
“Among the kinases involved in AJ dynamics is the non-receptor tyrosine kinase SRC (Lilien and Balsamo, 2005; Yeatman, 2004).”
BackgroundIsaías-Tizapa, R., Acosta, E., Tacuba-Saavedra, A., Catalán, M. A. M., & Navarro‐Tito, N. (2019) · Biomédica · doi:10.7705/biomedica.4313 · Cited by 4
“La Src regula múltiples procesos celulares relacionados con la progresión tumoral, como la angiogénesis, la adhesión, la motilidad, la invasión y la migración celular, lo cual sugiere que la Src tiene un papel importante en el desarrollo del tumor y la metástasis (37-39).”
BackgroundLoss of Contact Inhibition of Locomotion in the Absence of JAM-A Promotes Entotic Cell Engulfments
Schwietzer, M. F., Thölmann, S., Kummer, D., Kaschler, A., Greune, L., Thüring, E.-M., Schmidt, M. A., Gerke, V., & Ebnet, K. (2022) · iScience · doi:10.1016/j.isci.2022.105144 · Cited by 4
“The analysis of the underlying molecular mechanism revealed that JAM-A recruits c-Src regulatory kinase (Csk) to limit the activity of Src which is a key regulator of cell motility (Yeatman, 2004).”
BackgroundTherapeutic strategies for treatment of pulmonary lymphangioleiomyomatosis
Krymskaya, V. P. (2014) · Expert Opinion on Orphan Drugs · doi:10.1517/21678707.2014.953481 · Cited by 4
“Pro-oncogene Src is a non-receptor protein tyrosine kinase with a well-established role in cancer and metastasis [56].”
Backgroundp130Cas controls the susceptibility of cancer cells to TGF-β-induced growth inhibition
Kang, Y. S., Jeong, D. E., Lee, E. K., Song, W. K., & Kim, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.07.037 · Cited by 4
Davis, T. B., Gupta, S., Yang, M., Pflieger, L. T., Rajan, M., Wang, H., Thota, R., Yeatman, T. J., & Pledger, W. J. (2022) · Cancers · doi:10.3390/cancers14061451 · Cited by 4
Self-citationBairy, S. K., Suneel Kumar, B. V. S., Bhalla, J. U. T., Pramod, A. B., & Ravikumar, M. (2009) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2009.00789.x · Cited by 6
“c-Src has been shown to play a vital role in myocardial infarction (5), stroke (6), osteoporosis (7), neurodegeneration (8), and is also involved in metastases and tumor progression, particularly those of breast, metastatic colorectal (9), ovarian (10) and pancreatic cancers (11–13).”
BackgroundEffects of the Src inhibitor saracatinib (AZD0530) on renal function in healthy subjects.
Dalton, R. N., Chetty, R., Stuart, M., Iacona, R. B., & Swaisland, A. J. (2010) · PubMed · Cited by 5
Tiganis, T. (2016) · Springer eBooks · doi:10.1007/978-1-4939-3649-6_5 · Cited by 5
Biology and Treatment of Basal-Like Breast Cancer
Han, B., Audeh, W., Jin, Y., Bagaria, S. P., & Cui, X. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-634-4_5 · Cited by 5
Hanrahan, A. J., Iyer, G., & Solit, D. B. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00002-3 · Cited by 7
Xu, J., Liu, K., Gong, Z., Liu, J., Lin, H., Lin, B., Li, W., Zhu, M., & Li, M. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101538 · Cited by 6
Src kinase slows collective rotation of confined epithelial cell monolayers
Pricoupenko, N., Marsigliesi, F., Marcq, P., Blanch-Mercader, C., & Bonnet, I. (2024) · Soft Matter · doi:10.1039/d4sm00827h · Cited by 5
“Src, the protein product of the c-src gene, is a non-receptor tyrosine kinase [23, 24] that phosphorylates a variety of protein substrates that perform specific cellular functions [25].”
BackgroundYegambaram, M., Pokharel, M. D., Sun, X., Lü, Q., Soto, J. E., Aggarwal, S., Maltepe, E., Fineman, J. R., Wang, T., & Black, S. M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26083815 · Cited by 3
Hanrahan, A. J., Iyer, G., & Solit, D. B. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-47674-4.00002-5 · Cited by 6
Study of hsa_circRNA_000121 and hsa_circRNA_004183 in papillary thyroid microcarcinoma
Bai, C., Yang, W., Ouyang, R., Li, Z., & Zhang, L. (2022) · Open Life Sciences · doi:10.1515/biol-2022-0080 · Cited by 3
“apoptosis, and angiogenesis, as well as cell invasion and metastasis of malignant tumors [35].”
BackgroundTraditional Chinese Medicine Targeting Sarcoma Virus Oncogene-related Diseases
Wang, Y., Wang, X., Su, K., & Yang, Y. (2023) · Current Cancer Drug Targets · doi:10.2174/1568009623666230426093244 · Cited by 3
Seeking a better understanding of the non-receptor tyrosine kinase, SRMS
Goel, R. K., Kim, N., & Lukong, K. E. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16421 · Cited by 3
“This residue corresponds to Y447 in BRK, Y497 in FRK, and Y530 in human c-Src (Y527 in chicken c-Src) [8].”
BackgroundInsights to develop tau‐directed therapeutics to protect the synaptic integrity for tauopathies
Cha, E., Kim, H. J., & Lim, S. M. (2023) · Bulletin of the Korean Chemical Society · doi:10.1002/bkcs.12792 · Cited by 4
Shimpi, A. A., Williams, E. D., Lu, L., Tamir, T. Y., White, F. M., & Fischbach, C. (2023) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.3c01034 · Cited by 3
Périco, L. L., Vegso, A. J., Baggio, C. H., & MacNaughton, W. K. (2024) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00284.2023 · Cited by 3
Protein Kinases and Protein Phosphatases in Signal Transduction Pathways
Sawyer, T. K. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00070-5 · Cited by 5
Karim, S., Mirza, Z., Kamal, M. A., Abuzenadah, A. M., & Al-Qahtani, M. H. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527313666141023122803 · Cited by 3
Interplay of Matrix Stiffness and c-SRC in Hepatic Fibrosis
Görtzen, J., Schierwagen, R., Bierwolf, J., Klein, S., Uschner, F. E., van der Ven, P., Fürst, D. O., Strassburg, C. P., Laleman, W., Pollok, J., et al. (2016) · Journal of Hepatology · doi:10.1016/s0168-8278(16)01370-2 · Cited by 3
Structural basis of constitutive c-Src kinase activity due to R175L and W118A mutations
Gul, M., Ahmad, N., & Rashid, S. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.2010600 · Cited by 3
“It plays an imperative role in many signal transduction pathways ranging from cell proliferation to growth and survival (Amata et al., 2014; Summy & Gallick, 2006; Yeatman, 2004).”
BackgroundA Polymorphic Variant of AFAP-110 Enhances cSrc Activity
Clump, D. A., Yu, J., Cho, Y., Gao, R., Jett, J. E., Zot, H. G., Cunnick, J. M., Snyder, B. N., Clump, A. C., Dodrill, M., et al. (2010) · Translational Oncology · doi:10.1593/tlo.10106 · Cited by 3
“cSrc promotes motility and invasion, alteration of adhesion, and epithelial-mesenchymal transition [8,9].”
BackgroundLund, S. C., Brábek, J., & Hanks, S. K. (2008) · Molecular Carcinogenesis · doi:10.1002/mc.20466 · Cited by 3
“There has been renewed interest in Src as a therapeutic target in the treatment of cancer including colorectal cancer [23,42].”
BackgroundHead and Neck Squamous Cell Carcinoma
Fury, M. G., & Pfister, D. G. (2008) · Elsevier eBooks · doi:10.1016/b978-141603703-3.10038-x · Cited by 3
Yadav, V., Sharma, K., Bhattacharya, S., Talwar, P., Purohit, P. K., & Saini, N. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120906 · Cited by 3
RetractedLipid-driven Src self-association modulates its transformation capacity
Mohammad, I.-L., Giannotti, M. I., Fourgous, E., Boublik, Y., Fernández, A., Roux, A. L., Sirvent, A., Taulés, M., Roche, S., & Pons, M. (2025) · Life Science Alliance · doi:10.26508/lsa.202403019 · Cited by 3
“Deregulation of Src is frequently observed in human cancers and has been linked to tumor progression (Aligayer et al, 2002; Yeatman, 2004).”
Zhang, Y., Ruan, L., Li, X., Si, W., Yang, P., Ba, H., & Chen, Z. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s520390 · Cited by 2
Xu, B., Xiang, P., Yang, X., Zhang, T., Liu, Y., Tang, F., He, Z., & Zhou, J. (2026) · International Journal of Surgery · doi:10.1097/js9.0000000000004970 · Cited by 2
Role of PTPRT in obesity and its substrate paxillin tyrosine-88 in colorectal cancer
Scott, A. J. (2014) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 2
Therapeutic Intervention of Signaling Pathways in Colorectal Cancer
Chandra, V., Tiwari, A., Singh, R. P., & Desai, K. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-72702-4_8 · Cited by 2
Mondal, S., Vishakha, S., Kajal, K., Wahan, S. K., Kurmi, B. D., & Patel, P. (2023) · Current Organic Chemistry · doi:10.2174/1385272827666230220105034 · Cited by 2
ZHANG, P., He, J., LIU, J., Zhang, X., ZHANG, W., LIU, M., WANG, Y., Wang, Y., HUANG, W., & LIU, Z. (2020) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.647 · Cited by 2
“Non-receptor tyrosine kinase (Src), a kind of well-known non-receptor protein tyrosine kinase, plays a critical role in the regulation of many normal cellular transduction pathways such as cell proliferation[1], differentiation, adhesion, apoptosis and angiogenesis[2].”
BackgroundSrc Regulates the Expression of Lin28: Implications for Cell Growth, Adhesion, and Communication
Khusial, P. R., Vadla, B., & Goldberg, G. S. (2009) · Cell Communication & Adhesion · doi:10.1080/15419060902825980 · Cited by 2
“E-mail: garygoldberg@comcast.net 407 Cell Communication and Adhesion, 15: 407 409, 2009 Copyright # Informa UK Ltd. ISSN 1541-9061 print / 1543-5180 online DOI: 10.1080/15419060902825980 integrins and connexins (Pahujaa et al. 2007; Yeatman 2004).”
BackgroundInfluentialMorgan, J. C., Majors, J. E., & Galileo, D. S. (2005) · Clinical & Experimental Metastasis · doi:10.1007/s10585-005-6930-4 · Cited by 2
Chen, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.25121 · Cited by 2
The EGFR/ErbB Family in Breast Cancer: From Signalling to Therapy
Köstler, W. J., & Yarden, Y. (2010) · Springer eBooks · doi:10.1007/978-3-0346-0094-1_1 · Cited by 2
Src tyrosine kinase is crucial for potassium channel function in human pulmonary
Nagaraj, C., Tang, B., Wygrecka, M., Hrzenjak, A., Kwapiszewska, G., Stacher, E., Lindenmann, J., Weir, Ε. K., Olschewski, H., & Olschewski, A. (2013) · Cited by 2
SFK Inhibitors as New Strategy for RMS Treatment
Bagella, L., & Marchesi, I. (2016) · Chemotherapy Open access · doi:10.4172/2167-7700.1000189 · Cited by 2
“These enzymes are involved in several biological processes as cell proliferation, adhesion, invasion and motility; their expression or activity is frequently altered in cancer [14].”
BackgroundLin, L., Wu, M.-H., Pidugu, V. K., Ho, I., Su, T., & Lee, T. (2017) · Oncotarget · doi:10.18632/oncotarget.15065 · Cited by 3
“com/oncotarget Src and other Src family kinases are overexpressed and participate in numerous signaling pathways in various human cancers [49].”
The Prognostic Value of Tyrosine Kinase SRC Expression in Locally Advanced Rectal Cancer
Rühlmann, F., Nietert, M. M., Sprenger, T., Wolff, H. A., Homayounfar, K., Middel, P., Bohnenberger, H., Beißbarth, T., Ghadimi, Β. M., Liersch, T., et al. (2017) · Journal of Cancer · doi:10.7150/jca.16980 · Cited by 2
Sarkar, D., & Fisher, P. B. (2011) · Cambridge University Press eBooks · doi:10.1017/cbo9780511976117.007 · Cited by 2
Plakophilin-2 induced EGFR phosphorylation: a focus on the intracellular activators of EGFR
Arimoto, K., Weng, S., & Zhang, D. (2015) · Receptors & Clinical Investigation · doi:10.14800/rci.485 · Cited by 2
“Src is known to be involved in the signaling and cross talk between several mitogenic pathways, such as the ER (Estrogen Receptor) and EGFR family signaling pathways ([26]).”
BackgroundAdvances in targeted therapies for metastatic colorectal cancer
Pérez-García, J. M., Capdevila, J., Macarulla, T. M., Ramos, F. J., Élez, E., Ruiz-Echarri, M., & Tabernero, J. M. (2009) · Therapy · doi:10.2217/thy.09.11 · Cited by 2
Роль PDLIM4 и c-Src в развитии рака молочной железы
Kravchenko, D. S., Фролова, Е. И., Кравченко, Ю. Е., Chumakov, S. P., Frolova, E. I., & Kravchenko, J. E. (2016) · Molecular Biology · doi:10.7868/s0026898416010092 · Cited by 2
Src kinase inhibitors for the treatment of sarcomas: Cellular and molecular mechanisms of action
Shor, A. C. (2007) · Digital Commons - University of South Florida (University of South Florida) · Cited by 2
Mohammad, I.-L., Carvajal, J., Fernández, A., Taulés, M., Fourgous, E., Boublik, Y., Roux, A. L., Roche, S., & Pons, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.05.31.494233 · Cited by 2
“Overactivation of c-Src, the prototypical SFK, is associated to poor prognosis in many cancers (2,3).”
BackgroundQin, J., Guo, J., Tang, G., Li, L., & Yao, S. Q. (2023) · Angewandte Chemie · doi:10.1002/ange.202218412 · Cited by 1
Analysis of the Role of the SRC Tyrosine Kinase and Podoplanin in the Process of Entosis
Gaweł, A. M., Godlewska, M., Biały, Ł. P., & Młynarczuk-Biały, I. (2025) · Cancers · doi:10.3390/cancers17193173 · Cited by 2
“SRC is recognized as a key regulator of motility [20].”
Zhao, Y., Lv, J., Zhang, W., Deng, R., Li, C., Wang, L., Zhang, T., Liu, F., Ma, K., Wu, Z., et al. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00971-z · Cited by 1
“Studies indicate that the interaction of NKA α 1 inhibits SRC phosphorylation, thereby modulating the downstream signaling cascades associated with SRC, including PI3K, RAS/RAF/ERK, and PLC/PKC, which are critical for cell proliferation, differentiation, and apoptosis [18].”
CLDND1 as a prognostic ferroptosis-associated biomarker in oral squamous cell carcinoma
Zang, X., Di, Y., Liu, Y., Sun, X., Zhang, S., Li, X., & Wang, X. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152788 · Cited by 1
Madalageri, M., Sadashivanavar, V., Kinnal, R., Atchou, K., & Pai, K. S. R. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.154083 · Cited by 1
A Structural Perspective on Non-covalent Targeting of Conserved Polar Residues in Protein Kinases
Nasief, N. N., Patel, K. B., Ogboo, B. C., & Heppner, D. E. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6c00330 · Cited by 1
Liu, Q., Zhang, Y., Jernigan, D. L., & Fatatis, A. (2011) · Springer eBooks · doi:10.1007/978-94-007-2558-4_11 · Cited by 1
Efficacy of dasatinib for the treatment of intractable chronic myeloid leukemia
Khoury, J., Lima, Arellano, Holloway, Shepard, McMillan, & Khoury, J. (2010) · Journal of Blood Medicine · doi:10.2147/jbm.s7158 · Cited by 1
“DAS targets pathways involved in regulation of tissue interstitial fluid pressure ( PDGFR-b),(29,30) and permeability of pleural/ pulmonary vasculature (SRC, YES) which may explain the occurrence of these effusions.(29,31,32) Multivariate analyses have identified patients at risk for the development of pleural effusio…”
Background“Personalizing” Therapy for Non-Small Cell Lung Cancer
D’Cunha, J. (2010) · Seminars in Thoracic and Cardiovascular Surgery · doi:10.1053/j.semtcvs.2010.08.005 · Cited by 1
Electrochemical enzymatic biosensors using carbon nanofiber nanoelectrode arrays
Li, J., Li, Y., Swisher, L. Z., Syed, L. U., Prior, A. M., Nguyen, T. A., & Hua, D. H. (2012) · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE · doi:10.1117/12.928672 · Cited by 1
Decreased expression of c-Src in human transitional cell carcinoma
Shen, C., Tseng, Y.-S., Tung, C., Chen, S.-Y., & Lee, Y. (2014) · Biomarkers and Genomic Medicine · doi:10.1016/j.bgm.2014.01.004 · Cited by 1
Inhibition of the Src Oncogene: Therapeutic Potential in Ovarian Carcinoma
Han, L. Y., & Sood, A. K. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7216-3_5 · Cited by 1
“kinase activity and has been implicated in a variety of human cancers, including ovarian carcinomas [3–6].”
BackgroundKim, D., Won, K.-H., Moon, S. H., & Lee, H. (2015) · Asian-Australasian Journal of Animal Sciences · doi:10.5713/ajas.14.0923 · Cited by 1
“In the results of pathway analysis, “Adherens junctions” and “Focal adhesion” pathways were the two main types of junction that were modified by ISA adjuvants, which are known to mediate adhesion in epithelial cells (Yeatman, 2004).”
BackgroundTyrosine Kinase Signaling Pathways in Normal and Cancer Cells
Marcinkowska, E., & Gocek, E. (2016) · Resistance to targeted anti-cancer therapeutics · doi:10.1007/978-3-319-46091-8_1 · Cited by 2
Nanno, S., Fukuda, T., Noda, T., Uchikura, E., Awazu, Y., Imai, K., Yamauchi, M., Yasui, T., & Sumi, T. (2022) · Molecular and Clinical Oncology · doi:10.3892/mco.2022.2580 · Cited by 1
“Among these, Fyn, c‐Src, and Yes are expressed ubiquitously, whereas the others exhibit restricted tissue expression (7,18,19).”
BackgroundModulation of Functional Phosphorylation Sites by Basic Residues in the Unique Domain of c-Src
Láng, A., Fernández, A., Díaz‐Lobo, M., Vilanova, M., Cárdenas, F., Gairí, M., & Pons, M. (2023) · Molecules · doi:10.3390/molecules28124686 · Cited by 1
“It mediates signal transduction processes related to cell migration, invasion, and survival [1].”
BackgroundHao, H., Bian, Y., Yang, N., Ji, X., Bao, J., & Zhu, K. (2024) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2024.110286 · Cited by 1
Note on Three Classes of Data Grid Operations
Rajasekar, A., Xu, H., & Moore, R. (2014) · Journal of Computer and Communications · doi:10.4236/jcc.2014.26001 · Cited by 1
Ren, Y., Wang, Q., & Li, X. (2017) · Indian Journal of Pharmaceutical Education and Research · doi:10.5530/ijper.51.1.7 · Cited by 1
Targeting the ErbB Family in Head and Neck Cancer
Kiseleva, A. A., Beck, T. N., Serebriiskii, I. G., Liu, H., Burtness, B. A., & Golemis, E. A. (2018) · Current cancer research · doi:10.1007/978-3-319-78762-6_2 · Cited by 3
Drosophila Cancer Modeling Using the Eye Imaginal Discs
Gangwani, K., Snigdha, K., Atkins, M., Singh, S. R., & Kango‐Singh, M. (2020) · Springer eBooks · doi:10.1007/978-3-030-42246-2_9 · Cited by 2
Noguchi, R., Yoshimatsu, Y., Sei, A., Yoshida, H., Katou, T., & Kondo, T. (2021) · Journal of Electrophoresis · doi:10.2198/jelectroph.65.23 · Cited by 1
Metadata
- Authors
- Yeatman, T. J.
- Affiliations
- Moffitt Cancer Center (US)
- Corresponding author
- Yeatman, Timothy J.
- ORCID
- Yeatman, Timothy J.
- Venue
- Nature Reviews Cancer
- Published
- 2004-06-01
- Volume
- 4
- Issue
- 6
- Pages
- 470-480
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2036988959
- Cited by
- 1,113
- References
- 115
- Citations by year
- 2026: 17 · 2025: 21 · 2024: 20 · 2023: 43 · 2022: 43 · 2021: 46 · 2020: 44 · 2019: 39 · 2018: 49 · 2017: 44 · 2016: 69 · 2015: 56 · 2014: 72 · 2013: 79 · 2012: 73
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
- Keywords
- Src kinase, non-receptor tyrosine kinase, cancer, metastasis, cell invasion, cell motility, cell proliferation, anticancer agents, tumor progression
- MeSH terms
- Antineoplastic Agents, Cell Division, Humans, Neoplasm Invasiveness, Neoplasm Metastasis, Neoplasms, Neovascularization, Pathologic, Phenotype, Gene Expression Regulation, Neoplastic, Genes, src, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.